China’s Orient Gene lists higher in Shanghai STAR Market debut

China’s Orient Gene lists higher in Shanghai STAR Market debut

Medicine, biotechnology, DNA, genetics and healthcare. Image: Pixabay

06 February, 2020

Getein Biotech Guangzhou Wondfo Biotech Wuhan Easydiagnosis Biomedicine Zhejiang Orient Gene Biotech

Printed by Unregistered user on Tue, 23 Dec 2025 15:15:53 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese gene testing firm Genetron files for US IPO

Vickers-backed Hillstone Networks raises $133m in Shanghai STAR IPO

Read more from Greater China

China’s LandSpace completes ‘tutoring’ process ahead of Shanghai IPO

Policy & Regulations

US bars approvals of new models of China’s DJI, other foreign drones